Back to results
US 2014/0179671 A1Published application
Fused ring azadecalin glucocorticoid receptor modulators
AssigneeCorcept Therapeutics, Inc.
InventorsRobin D. Clark, Nicholas C. Ray, Paul M. Blaney, Christopher A. Hurley, Karen Williams
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel class of fused ring azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
Claims9
1-32. (canceled)
A compound having the formula
- wherein
- L1-R1 is a member selected from unsubstituted alkyl and —CH2—OR1A, wherein R1A is hydrogen or unsubstituted alkyl;
- L2 is a bond;
- R2 has the formula:
- wherein
- R2G is a member selected from hydrogen, halogen, unsubstituted (C1-C10) alkyl, —CN, and —CF3;
- J is phenyl;
- t is an integer from 0 to 5;
- X is —S(O2)—;
- and
- R5A is halogen,
- or a pharmaceutically acceptable salt thereof.
9 more elements
Dependencies are inferred from the claim text.